HomeNDC LookupRxCUI directory › RxCUI 2665269

Potassium chloride 10 MEQ Powder for Oral Solution — RxCUI 2665269

RxNorm drug concept · Semantic clinical drug
RxCUI 2665269 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 3 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2665269
Official namePotassium chloride 10 MEQ Powder for Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asK+ chloride 10 MEQ Powder for Oral Solution; Pot chloride 10 MEQ Powder for Oral Solution; potassium chloride 10 MEQ (0.75 GM) Powder for Oral Solution
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)1,299 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Potassium Chloride: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You're right that food is the first line — bananas, potatoes, and leafy greens are all rich in potassium. But sometimes diet alone isn't enough, especially if you're taking a diure...
  • Why did my doctor prescribe potassium chloride? I thought potassium just came from bananas.
  • Yes — always take oral tablets or capsules with a meal or right after eating. Taking them on an empty stomach can irritate or even ulcerate the lining of your stomach or intestines...
  • Do I have to take it with food? What happens if I forget?
📖 Read our full Potassium Chloride guide →

🕸️ Concept Web — How Potassium chloride 10 MEQ Powder for Oral Soluti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Potassium chloride 10 MEQ Powder for Oral Solution RxCUI 2665269

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Potassium chloride 8591
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pokonza 2665270
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Potassium chloride Powder for Oral Solution 1867543
    • Potassium chloride Oral Powder Product 1295399
    • Potassium chloride Oral Product 1160489
    • Potassium chloride Powder for Oral Solution [Pokonza] 2665274
    • Pokonza Oral Powder Product 2665273
    • Pokonza Oral Product 2665272
    • Powder for Oral Solution 1540455
    • Oral Powder Product 1294711
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Potassium chloride 10 MEQ SCDC · 316543
  • Potassium chloride Powder for Oral Solution SCDF · 1867543
  • Potassium chloride Oral Powder Product SCDG · 1295399
  • Potassium chloride Oral Product SCDG · 1160489

Brand-Name Concepts

  • Potassium chloride 10 MEQ Powder for Oral Solution [Pokonza] SBD · 2665275
  • Potassium chloride 10 MEQ [Pokonza] SBDC · 2665271
  • Potassium chloride Powder for Oral Solution [Pokonza] SBDF · 2665274
  • Pokonza Oral Powder Product SBDG · 2665273
  • Pokonza Oral Product SBDG · 2665272
  • Pokonza BN · 2665270

📦 FDA Products & Package NDCs

1 product · 3 package NDCs
3 package NDCs map to RxCUI 2665269 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
15370-0305-04 4 POUCH in 1 CARTON (15370-305-04) / .79 g in 1 POUCH (1537... POKONZA Carwin Pharmaceutical Associates, LLC 2023-09-19
15370-0305-30 30 POUCH in 1 CARTON (15370-305-30) / .79 g in 1 POUCH (153... POKONZA Carwin Pharmaceutical Associates, LLC 2024-03-18
15370-0305-60 60 POUCH in 1 CARTON (15370-305-60) / .79 g in 1 POUCH (153... POKONZA Carwin Pharmaceutical Associates, LLC 2023-09-19
Observed labelers: Carwin Pharmaceutical Associates, LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ea · median
$28.4193
Range $28.4193–$28.4193 · middle 50% $28.4193–$28.4193 · 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.